Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Your Article Summary
See Latest ArticlesComplete soft tissue sarcoma resection is a viable treatment option for select elderly patients
Annals of Surgical Oncology, 06/29/09
Lahat G et al. - In a study to evaluate the outcome of elderly pts amenable to complete surgical resection treated at a single institution, it seems that properly selected elderly pts can safely undergo extensive soft tissue sarcoma (STS) resections. Until more effective therapies become available, surgery in the elderly is indicated and remains the best means for STS control.
Methods- Prospectively accrued data were used to identify pts with primary STS age ≥65 yrs (n=325) who underwent complete macroscopic resection at 1 institution.
- Univariable and multivariable analyses were performed to identify prognostic factors.
- Median age at presentation was 72 yrs; 179 pts (55.1%) had associated comorbidities with an ASA score of ≥3.
- Extremity was the most common site (57.1%; n=186), undifferentiated pleomorphic sarcoma the most common histology (60.4%; n=197); 232 (71.2%) were high grade, 222 (68.3%) were >5 cm.
- 30-day postoperative mortality was 0.9% (n=3); overall complication rate was 30.7% (n=100), and mean postoperative hospital stay was 9 days.
- Estimated median survival was 96 mos, 5-yr disease-specific survival (DSS) was 63%.
- Multivariable analysis identified age ≥75 yrs, tumor size: 5–15 vs <5 cm, or >15 vs <5 cm, and high-grade as significant independent adverse prognostic factors.
- Compared with pts aged 65–74 yrs, older pts had more high-grade tumors, received chemotherapy less often, developed different patterns of recurrence, and exhibited a shorter median survival (70 mos).
Today in Surgical Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Localized resection for colon cancer
Surgical Oncology, 11/04/09
Quality of surgery for rectal carcinoma: comparison between open and laparoscopic approaches
The American Journal of Surgery, 11/03/09
Original contribution: surgeon recommendations and receipt of mastectomy for treatment of breast cancer
JAMA, 10/28/09
Sponsor
Article Search
Sponsor